Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity (Q34617633)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity |
scientific article |
Statements
1 reference
Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity (English)
1 reference
Anita K Gandhi
1 reference
Derek Mendy
1 reference
Michelle Waldman
1 reference
Gengxin Chen
1 reference
Emily Rychak
1 reference
Karen Miller
1 reference
Svetlana Gaidarova
1 reference
Yan Ren
1 reference
Maria Wang
1 reference
Michael Breider
1 reference
Gilles Carmel
1 reference
Afshin Mahmoudi
1 reference
Pilgrim Jackson
1 reference
Mahan Abbasian
1 reference
Brian E Cathers
1 reference
Peter H Schafer
1 reference
Tom O Daniel
1 reference
Antonia Lopez-Girona
1 reference
Anjan Thakurta
1 reference
Rajesh Chopra
1 reference
28 October 2013
1 reference
1 reference
164
1 reference
2
1 reference
233-244
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference